Self-replicating rna and uses thereof
AssigneeTrustees of Boston University
InventorsJoshua Edward MCGEE, Jack Rainier KIRSCH, Eric BRESSLER, Mark W. GRINSTAFF, Wilson WONG, Lidya Yidnekachew Sertse, Kexin Li
Life of this patent
Estimating the term…
Abstract
The technology described herein is directed to compositions and methods for modifying and controlling the activity of cells by expression of proteins from self-amplifying RNA (saRNA). Also described herein are compositions and methods for modifying and controlling the activity of cells by expression of proteins from self-amplifying RNA that is substituted with chemically modified nucleotides.
Claims30
A self-amplifying RNA (saRNA) comprising at least 25% modified nucleotides, wherein the modified nucleotides comprise a pyrimidine nucleoside phosphate with a moiety on carbon 5 of the pyrimidine, wherein the moiety is selected from the group consisting of methyl, ethyl, propyl, trifluoromethyl, hydroxymethyl, hydroxyethyl, and hydroxypropyl functional groups, and at least one cargo of interest.
A self-amplifying RNA (saRNA) comprising from 5′ to 3″:
- (a) a 5′ cap;
- (b) non-structural protein 1 (nsp1), non-structural protein 2 (nsp2), non-structural protein 3 (nsp3), and/or non-structural protein 4 (nsp4), each derived from at least one virus;
- (c) a subgenomic promoter (SGP) derived from at least one virus;
- (d) a 5′ untranslated region (UTR) derived from at least one virus;
- (e) at least one cargo of interest;
- (f) a 3′ untranslated region (UTR) derived from at least one virus;
- and
- (g) a poly-A tail.
Dependencies are inferred from the claim text.